関節内補充療法市場：用量別、関節炎タイプ別、エンドユーザー別、地域別

世界の関節内補充療法市場は、2025年には41億5,000万米ドルと推定され、2032年には71億1,000万米ドルに達すると予測され、2025～2032年にかけてCAGR8.0％で成長すると予測されています。

図.関節内補充療法市場シェア（%）、2025年地域別

関節内補充療法は、変形性膝関節症の疼痛管理に用いられる整形外科治療法です。ヒアルロン酸（ヒアルロン酸としても知られる）を膝関節に注入します。ヒアルロン酸は関節の潤滑油や衝撃吸収剤として働いています。ヒアルロン酸は、変形性関節症によって減少した関節内のレベルを補充します。これにより、変形性関節症に罹患した膝の滑液の粘性を補うことで、痛みを軽減し、可動性を改善することができます。関節内補充療法は、変形性膝関節症の症状を長期間緩和する非外科的治療法です。

市場力学

世界の関節内補充療法市場は、変形性膝関節症やそれに伴う関節痛を発症しやすい高齢者の増加によって牽引されています。推定によると、現在世界では3億3,000万人以上が変形性関節症に苦しんでいます。これは今後数年で大幅に増加すると予測されています。さらに、先進的な非侵襲的治療法に対する意識の高まりや、関節内補充療法に対する有利な償還施策が、市場を後押ししています。しかし、栄養補助食品のような代替治療法への嗜好や、ヒアルロン酸注入による疼痛緩和の効果や持続時間の限界によって、市場の成長は抑制される可能性があります。患者固有のヒアルロン酸製剤を開発するための3Dプリンティングとロボット技術の統合は、この市場に有利な機会を記載しています。

研究の主要特徴

• この調査レポートは、世界の関節内補充療法市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模と複合年間成長率（CAGR%）を掲載しています。
• さまざまなセグメントにわたる潜在的な収益機会を解明し、この市場の魅力的な投資提案マトリクスを説明しています。
• また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域による展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
• 企業ハイライト、製品ポートフォリオ、主要なハイライト、業績、戦略などのパラメータに基づいて、世界の関節内補充療法の主要企業プロファイルを掲載しています。
• このレポートから洞察は、マーケティング担当者や企業の経営陣が、将来の製品の発売、タイプのアップグレード、市場拡大、マーケティング戦術に関する情報に基づいた意思決定を行うことを可能にします。
• 世界の関節内補充療法市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この産業の様々な利害関係者に対応しています。
• 利害関係者は、世界の関節内補充療法市場を分析する際に使用される様々な戦略マトリックスを通じて、意思決定を容易にすることができます。

目次

第1章 調査の目的と前提条件

• 調査目的
• 前提条件
• 略語

第2章 市場展望

• レポートの説明
  • 市場の定義と範囲
• エグゼクティブサマリー
• 一貫型機会マップ（COM）

第3章 市場力学、規制、動向分析

• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• 影響分析
• 市場動向
• 買収と提携のシナリオ
• 技術概要
• 規制シナリオ
• PEST分析

第4章 世界の関節内補充療法市場-コロナウイルス（COVID-19）パンデミックの影響

• 全体的な影響
• 需要と供給への影響
• COVID-19による市場への影響

第5章 世界の関節内補充療法市場、用量別、2020～2032年

• イントロダクション
• 1回注射
• 3回注射
• 5回注射

第6章 世界の関節内補充療法市場、関節炎タイプ別、2020～2032年

• イントロダクション
• 変形性関節症
• 関節リウマチ

第7章 世界の関節内補充療法市場、エンドユーザー別、2020～2032年

• イントロダクション
• 病院
• 専門クリニック
• 外来手術センター
• その他

第8章 世界の関節内補充療法市場、地域別、2020～2032年

• イントロダクション
• 北米
• ラテンアメリカ
• 欧州
• アジア太平洋
• 中東
• アフリカ

第9章 競合情勢

• Anika Therapeutics Inc
• Seikagaku Corporation
• Ferring Pharmaceuticals
• Bioventus
• Fidia Farmaceutici S.P.A.
• Mylan N.V.
• Sanofi S.A.
• ORTHOGENRX
• Teva Pharmaceutical Industries Ltd.
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Zimmer Biomet
• Aptissen
• Wellchem Pharmaceuticals Pte Ltd.
• Juniper Biologics
• Ono Pharmaceutical Co., Ltd

第10章 アナリストの視点

• 隆盛と衰退
• 一貫型機会マップ

第11章 参考文献と調査手法

• 参考文献
• 調査手法

Global Viscosupplementation Market is estimated to be valued at USD 4.15 Bn in 2025 and is expected to reach USD 7.11 Bn by 2032, growing at a compound annual growth rate (CAGR) of 8.0% from 2025 to 2032.

Figure. Viscosupplementation Market Share (%), By Region 2025

Viscosupplementation is an orthopedic treatment method used to manage osteoarthritis knee pain. It involves injecting hyaluronic acid, also known as hyaluronan, into the knee joint. Hyaluronic acid acts as a lubricant and shock absorber in the joints. It replenishes levels in the joint that diminish with osteoarthritis. This helps reduce pain and improve mobility by supplementing the viscous nature of the synovial fluid in knees affected by osteoarthritis. Viscosupplementation therapy is a non-surgical treatment option that provides relief from knee osteoarthritis symptoms for extended periods of time.

Market Dynamics:

The global viscosupplementation market is driven by the rising geriatric population which is more prone to develop osteoarthritis and the associated joint pains. As per estimates, over 330 million people currently suffer from osteoarthritis globally. This is projected to increase substantially in the coming years. Moreover, growing awareness about advanced non-invasive treatment alternatives and favorable reimbursement policies for viscosupplementation procedures are boosting the market. However, the market growth can be restrained by the preference for alternative treatment methods like dietary supplements and limitations in the efficacy and duration of pain relief provided by hyaluronic acid injections. The integration of 3D printing and robotic technologies to develop patient-specific hyaluronic acid formulations provides lucrative opportunities in this market.

Key Features of the Study:

• This report provides in-depth analysis of the global viscosupplementation market, and provides market size (US$ Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global viscosupplementation market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study includes Anika Therapeutics Inc., Seikagaku Corporation, Ferring Pharmaceuticals, Bioventus, Fidia Farmaceutici S.P.A., Mylan N.V., Sanofi S.A., OrthogenRx, Teva Pharmaceutical Industries Ltd, Johnson & Johnson., F. Hoffmann-La Roche AG, Zimmer Biomet, Aptissen, Wellchem Pharmaceuticals Pte Ltd., Juniper Biologics, and Ono Pharmaceutical Co., Ltd.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global viscosupplementation market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global viscosupplementation market.

Market Segmentation

• Dosage:
  • Single Injection
  • Three Injection
  • Five Injection
• Arthritis Type:
  • Osteoarthritis
  • Rheumatoid Arthritis
• End User:
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Others
• Region:
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
• Company Profiles:
  • Anika Therapeutics Inc.
  • Seikagaku Corporation
  • Ferring Pharmaceuticals
  • Bioventus
  • Fidia Farmaceutici S.P.A.
  • Mylan N.V.
  • Sanofi S.A.
  • OrthogenRx
  • Teva Pharmaceutical Industries Ltd
  • Johnson & Johnson.
  • Hoffmann-La Roche AG
  • Zimmer Biomet
  • Aptissen
  • Wellchem Pharmaceuticals Pte Ltd.
  • Juniper Biologics
  • Ono Pharmaceutical Co., Ltd

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Dosage
  • Market Snapshot, By Arthritis Type
  • Market Snapshot, By End User
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Opportunities
• Impact Analysis
• Market Trends
• Recent Developments
• Acquisitions and Partnerships Scenario
• Technology Overview
• Regulatory Scenario
• PEST Analysis

4. Global Viscosupplementation Market- Impact of Coronavirus (COVID-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the Market

5. Global Viscosupplementation Market, By Dosage, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Single Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Three Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Five Injection
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

6. Global Viscosupplementation Market, By Arthritis Type, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Osteoarthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Rheumatoid Arthritis
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

7. Global Viscosupplementation Market, By End User, 2020 - 2032, (US$ Billion)

• Overview
  • Market Share Analysis, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, 2020 - 2032
  • Segment Trends
• Hospitals
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Specialty Clinics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Ambulatory Surgical Centers
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (US$ Billion)

8. Global Viscosupplementation Market, By Region, 2020 - 2032, (US$ Billion)

• Introduction
  • Market Share Analysis, By Region, 2025 and 2032 (%)
  • Y-o-Y Growth Analysis, For Regions, 2020-2032
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.S.
  • Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (US$ Billion)
  • GCC
  • Israel
  • Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Dosage, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Arthritis Type, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (US$ Billion)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (US$ Billion)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

• Anika Therapeutics Inc
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Seikagaku Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Ferring Pharmaceuticals
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Bioventus
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Fidia Farmaceutici S.P.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Mylan N.V.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Sanofi S.A.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• ORTHOGENRX
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Teva Pharmaceutical Industries Ltd.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Johnson & Johnson
• F. Hoffmann-La Roche AG
• Zimmer Biomet
• Aptissen
• Wellchem Pharmaceuticals Pte Ltd.
• Juniper Biologics
• Ono Pharmaceutical Co., Ltd

10. Analyst View

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

11. References and Research Methodology

• References
• Research Methodology
• About us and Sales Contact